Catalyst Wire Dossier Catalyst Wire Dossier

MF59-adjuvanted inactivated influenza vaccine (formulation 2008-2009)

influenza vaccine, MF59-adjuvanted · Novartis Vaccines
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MF59-adjuvanted inactivated influenza vaccine (formulation 2008-2009), covering 2016-01-28 to 2016-01-28. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of Surface Antigen, Inactivated, Adjuvanted With MF59C.1 Influenza Vaccine, Formulation 2008-2009 [Phase 2]

See pricing